Overview

Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate clinical pharmacology, efficacy and safety of FGTW in pediatric patients with congenital fibrinogen deficiency.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies